Financials Zai Lab Limited

Equities

ZLAB

US98887Q1040

Pharmaceuticals

Real-time Estimate Cboe BZX 10:48:36 2024-04-17 am EDT 5-day change 1st Jan Change
13.81 USD -4.23% Intraday chart for Zai Lab Limited -8.64% -48.52%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 2,753 11,913 6,059 2,946 2,688 1,424 - -
Enterprise Value (EV) 1 2,484 10,726 4,650 1,938 1,897 932.5 1,149 1,132
P/E ratio -13.7 x -39.1 x -8.29 x -6.63 x -7.9 x -4.54 x -7.63 x 115 x
Yield - - - - - - 1.39% -
Capitalization / Revenue 212 x 243 x 42 x 13.7 x 10.1 x 3.76 x 2.32 x 1.53 x
EV / Revenue 191 x 219 x 32.2 x 9.01 x 7.11 x 2.46 x 1.87 x 1.21 x
EV / EBITDA -12.5 x -36.1 x -6.7 x -4.89 x -5.3 x -2.81 x -6.42 x 108 x
EV / FCF -12.6 x -47.4 x -8.19 x -4.94 x -9.23 x -2.6 x -4.94 x -24.1 x
FCF Yield -7.93% -2.11% -12.2% -20.2% -10.8% -38.4% -20.3% -4.16%
Price to Book 9.63 x 10.2 x 4.35 x - 3.34 x 2.95 x 6.8 x 17.2 x
Nbr of stocks (in thousands) 66,199 88,024 96,409 95,972 98,349 98,718 - -
Reference price 2 41.59 135.3 62.85 30.70 27.33 14.42 14.42 14.42
Announcement Date 3/19/20 3/1/21 3/1/22 3/1/23 2/27/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 12.98 48.96 144.3 215 266.7 378.3 613.8 932.9
EBITDA 1 -199.4 -297.2 -693.6 -396.1 -357.5 -331.5 -178.9 10.52
EBIT 1 -203.2 -301.8 -700.1 -404.4 -366.6 -333.9 -191.1 -0.0893
Operating Margin -1,564.88% -616.45% -485.1% -188.04% -137.44% -88.27% -31.13% -0.01%
Earnings before Tax (EBT) 1 -194.3 -267.8 -703.4 -443.1 -334.6 -307.7 -169.1 0.275
Net income 1 -195.1 -268.9 -704.5 -443.3 -334.6 -307.5 -169.5 -2.4
Net margin -1,502.31% -549.26% -488.16% -206.14% -125.46% -81.27% -27.62% -0.26%
EPS 2 -3.030 -3.460 -7.580 -4.630 -3.460 -3.176 -1.890 0.1250
Free Cash Flow 1 -197 -226.2 -567.5 -392.2 -205.4 -358.2 -232.7 -47.05
FCF margin -1,517.52% -462% -393.26% -182.4% -77.01% -94.68% -37.91% -5.04%
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share 2 - - - - - - 0.2000 -
Announcement Date 3/19/20 3/1/21 3/1/22 3/1/23 2/27/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2019 S2 2020 S1 2020 S2 2021 S1 2021 Q3 2021 Q4 2021 S2 2022 Q1 2022 Q2 2022 S1 2022 Q3 2022 Q4 2022 S2 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 9.565 19.21 29.74 57.04 43.1 44.17 87.27 46.72 48.18 94.9 57.54 62.6 120.1 62.8 68.86 69.23 65.83 74.19 86.17 100.3 116.1
EBITDA 1 - - - - - -217.3 - -77.75 - - - - - - - - -121.5 -105.3 -91.23 -82.42 -66.31
EBIT 1 -117.3 -130.3 -171.5 -397.7 -83.2 -219.2 -302.4 -79.76 -98.72 -178.5 -128.6 -97.29 -225.9 -69.52 -89.5 -83.57 -124 -95.4 -89.17 -82.1 -79.41
Operating Margin -1,226.58% -678.12% -576.61% -697.19% -193.04% -496.24% -346.5% -170.71% -204.91% -188.07% -223.47% -155.42% -188.01% -110.71% -129.97% -120.72% -188.34% -128.59% -103.48% -81.83% -68.38%
Earnings before Tax (EBT) 1 -111.3 -128.2 -139.6 - -96.07 -211.3 - -82.17 -137.9 - -161.2 -61.77 - -49.14 -120.9 -69.15 -95.43 -89.85 -80.5 -73.8 -63.95
Net income 1 -111.8 -128.6 -140.3 - -96.41 -211.8 - -82.39 -137.9 - -161.2 -61.77 -223 -49.14 -120.9 -69.15 -95.43 -89.1 -81.17 -72.93 -64.63
Net margin -1,168.87% -669.43% -471.64% - -223.68% -479.56% - -176.34% -286.31% - -280.14% -98.67% -185.58% -78.26% -175.56% -99.89% -144.96% -120.1% -94.19% -72.7% -55.66%
EPS 2 -1.660 -1.740 -1.720 - -1.010 -2.240 - -0.8600 -1.440 - -1.680 -0.6500 - -0.5100 -1.250 -0.7100 -0.9800 -0.9100 -0.8300 -0.7467 -0.6600
Dividend per Share 2 - - - - - - - - - - - - - - - - - - - - -
Announcement Date 3/19/20 8/13/20 3/1/21 8/9/21 11/9/21 3/1/22 3/1/22 5/10/22 8/9/22 8/9/22 11/9/22 3/1/23 3/1/23 5/9/23 8/7/23 11/7/23 2/27/24 - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 269 1,187 1,409 1,008 791 491 275 292
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 -197 -226 -568 -392 -205 -358 -233 -47.1
ROE (net income / shareholders' equity) -71.5% -36.7% -55.3% -36.6% -36.3% -50.1% -48.3% -25.5%
ROA (Net income/ Total Assets) -59.4% -32.5% -48.5% -31.3% -29.7% -36.8% -25.4% 1.9%
Assets 1 328.6 826.4 1,454 1,415 1,128 834.8 667.6 -126.3
Book Value Per Share 2 4.320 13.30 14.50 - 8.190 4.880 2.120 0.8400
Cash Flow per Share -2.970 -2.780 -5.910 - - - - -
Capex 1 6.04 10.1 18.3 24.6 7.21 18.9 23.2 34.5
Capex / Sales 46.48% 20.69% 12.68% 11.43% 2.7% 4.99% 3.79% 3.7%
Announcement Date 3/19/20 3/1/21 3/1/22 3/1/23 2/27/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
14.42 USD
Average target price
54.12 USD
Spread / Average Target
+275.29%
Consensus
  1. Stock Market
  2. Equities
  3. ZLAB Stock
  4. Financials Zai Lab Limited